INVICTUS HIRES EX-HEINEKEN EXECUTIVE KEVIN SMITH AS VP RECREATIONAL SALES; SARAH HARDY AS VP MEDICAL SALES
September 17 2018 - 8:00AM
InvestorsHub NewsWire
Invictus hires former Heineken executive Kevin Smith as VP
Recreational Sales
Vancouver, BC
-- September 17, 2018 -- InvestorsHub NewsWire -- INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)
is pleased to announce the addition
of former Heineken executive Kevin Smith as Vice President
Recreational Sales, commencing October 1, 2018, and Sarah Hardy,
MBA, as Vice President Medical Sales, effective August 20,
2018.
As former Director of Sales at Heineken Canada,
Kevin developed the commercial strategy for Heineken in Western
Canada, led the execution of the sales organization’s annual plan,
developed relations with key customers in both private and
government channels and managed the distributor relationship with
Molson Coors. In his role as Vice President Recreational Sales,
Kevin will be responsible for building out a team of professionals
to maintain strong working relationships with liquor boards and
establish a presence in retail stores across the country. With
agreements already secured in British Columbia, Alberta, and
Saskatchewan, Kevin will oversee Invictus’ initial launch in
Western Canada and future development, including working in
partnership with GTEC Holdings Ltd. (“GTEC”) (TSXV: GTEC) to unveil multiple
retail stores in the coming weeks and months.
“I am excited to join the exceptional team that
Dan Kriznic has built at Invictus. I am passionate about the
Cannabis industry, excited to educate a diverse consumer base about
our brands and look forward to building an interactive retail
experience with our key customers,” said Kevin Smith, Vice
President Recreational Sales. “I think the demand for Cannabis has
been understated in Canada and look forward to leading the Invictus
sales team in exceeding our forecasts and long-term
growth”
Kevin brings to Invictus 16 years of experience
in both beverage alcohol and government sectors with a specialized
focus on the retail channel. In addition to his work with
Heineken, Kevin has had increasingly senior roles, including
Provincial Sales Manager for SABMiller Canada, Regional Sales
Manager at the British Columbia Lottery Corporation, and started
his career working with key customers at AB
InBev.
As a
former executive at top tier
companies, such as Mondalez, American Express, and Indivior, Sarah
brings a proven track record of driving bottom line growth,
building new markets, and optimizing profit across diverse industry
base. In her role as Vice President Medical Sales, Sarah will be
responsible for the development and implementation of the Company’s
strategic patient acquisition program directed at establishing
relationships with and educating medical clinics, medical doctors
and patients, and winning market share for medical cannabis sales.
Sarah will drive patient registration and sales
targets.
“As a former sales associate in the
pharmaceutical industry, I know how to drive sales and deliver a
superior client experience,” said Sarah Hardy, Vice President
Medical Sales. “I am thrilled to represent Invictus on the
front-line of this emerging industry, working to expand our
presence in the medical community.”
Sarah brings over 15 years of
experience across various sectors including CPG, Financial
Services, Healthcare and Professional Services. Sarah completed her
Bachelor of Commerce degree at UBC and holds her Executive MBA from
the Ivey Business School at the University of Western
Ontario.
“With
legalization around the corner, Invictus is working to build strong
relationships with clients in both the medical and recreational
markets,” said Dan Kriznic, Invictus Chairman and CEO. “Together,
with 30+ years of experience working in sales for some of the
biggest brands across a variety of sectors, Sarah and Kevin are
joining our team at the right time. Our goal is to deliver an
exceptional customer experience, across our robust distribution
network.”
For
more information, please visit www.invictus-md.com.
On
Behalf of the Board,
Dan
Kriznic
Chairman and CEO
Jessica
Martin
Vice
President, Public Relations and Regulatory
Affairs
(604)
537-8676
About Invictus
Invictus is a global cannabis company offering a
selection of products under a wide range of lifestyle brands. Our
integrated sales approach is defined by five pillars of
distribution including medical, adult-use, international, Licensed
Producer to Licensed Producer and retail stores.
Invictus has partnered with business leaders to
convey our corporate vision, including KISS music legend and
business mogul Gene Simmons as our Chief Evangelist Officer, and
global branding agency Authentic Brands Group. Invictus is
expanding its cultivation footprint, with two cannabis production
facilities fully licensed under ACMPR in Canada and a third
awaiting approval, featuring 100,000 square feet of available grow
space today with 200,000 expected by January 2019 and 1 million by
end of 2019. The Company will earmark 50 per cent of production to
the medical and recreational markets, respectively. To ensure
consistency in quality and supply, Invictus maintains all aspects
of the growing process through its subsidiary, Future Harvest
Development Ltd., a high-quality Fertilizer and Nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over 69 Health
Canada approved strains and a multifaceted distribution strategy
including medical, recreational, international and retail. For more
information visit www.invictus-md.com.
Cautionary Note Regarding Forward-Looking Statements:
This release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including the timing,
approval and completion of the Arrangement and related matters and
the potential production capacity of Invictus, are forward-looking
statements and contain forward-looking information. Generally,
forward-looking statements and information can be identified by the
use of forward-looking terminology such as "intends" or
"anticipates", or variations of such words and phrases or
statements that certain actions, events or results "may", "could",
"should", "would" or "occur". Forward-looking statements are based
on certain material assumptions and analysis made by the Company
and the opinions and estimates of management as of the date of this
press release, including that Invictus will be successful in
reaching its potential production capacity, its production
facilities will be completed as anticipated, regulatory approval
will be granted as anticipated, Invictus will reach full production
capacity on the timeline anticipated by the Company, and no
unforeseen construction delays will be experienced. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, the Company will not obtain the requisite
approvals to complete the Arrangement, Invictus will not be
successful in reaching its potential production capacity, its
production facilities will not be completed as anticipated, and
licenses or approvals being granted on terms or timelines that are
materially worse than expected by the Company. Although management
of the Company has attempted to identify important factors that
could cause actual results to differ materially from those
contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
Neither the TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Sep 2023 to Sep 2024